Caprock Group, Inc. Adma Biologics, Inc. Transaction History
Caprock Group, Inc.
- $2.43 Billion
- Q2 2024
A detailed history of Caprock Group, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 14,103 shares of ADMA stock, worth $278,816. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,103
Previous 13,680
3.09%
Holding current value
$278,816
Previous $90,000
74.44%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$369 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$287 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$260 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$176 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$159 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.88B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...